Showing results (381-390 of 434) with videos related to

Sort By:
Pageof 44
Archives of Gynecology and Obstetrics|March 22, 2022
The significance of transcervical ultrasound-guided radiofrequency ablation in the treatment of symptomatic fibroids: results of an expert consensus from German-speaking countriesThomas Römer, Ralf Bends, Ladina Christoffel, et al.
Zentralblatt Fur Gynakologie|January 1, 1996
[Results of long-term follow-up in treatment of endometriosis with the GnRH agonist leuprorelin acetate depot (Enantone-Gyn monthly depot)]P A Regidor, A E Schindler, K Bühler, et al.
Environmental Science & Technology|November 3, 2015
Smoldering Remediation of Coal-Tar-Contaminated Soil: Pilot Field Tests of STARGrant C Scholes, Jason I Gerhard, Gavin P Grant, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2001
Correlation of p53 mutations with resistance to platinum-based chemotherapy and shortened survival in ovarian cancerA Reles, W H Wen, A Schmider, et al.
Vox Sanguinis|January 1, 1996
CD8+ lymphocyte decrease in HIV disease: association with anti-CD4+ but not with anti-CD8+ lymphocyte autoantibodiesV Daniel, C Süsal, R Weimer, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|June 1, 1992
[Local and systemic humoral immune response to protein I of Neisseria gonorrhoeae]P K Kohl, M Kratofiel, R Görner, et al.
Clinical Therapeutics|January 1, 1992
Treatment of endometriosis with leuprorelin acetate depot: a German multicentre studyI Gerhard, A E Schindler, K Bühler, et al.
Zentralblatt Fur Gynakologie|January 1, 1994
[Treatment of endometriosis with the GnRH agonist leuprorelin acetate depot (Enatone-Gyn monthly depot): a multicenter study]A E Schindler, K Bühler, I Gerhard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 26, 2017
Ten-year results of intense dose-dense chemotherapy show superior survival compared with a conventional schedule in high-risk primary breast cancer: final results of AGO phase III iddEPC trialV Möbus, C Jackisch, H J Lück, et al.
British Journal of Cancer|September 16, 1999
Intron variants of the p53 gene are associated with increased risk for ovarian cancer but not in carriers of BRCA1 or BRCA2 germline mutationsS Wang-Gohrke, W Weikel, H Risch, et al.
Pageof 44